Cargando…
Co-Detection of VEGF-A and Its Regulator, microRNA-181a, May Indicate Central Nervous System Involvement in Pediatric Leukemia
Central nervous system (CNS) involvement is a leading cause of therapy-refractory pediatric acute lymphoblastic leukemia (pALL), which is aggravated by underdiagnosing CNS disease with the currently used cell-based approach of cerebrospinal fluid (CSF) diagnostics. Our study focused on developing no...
Autores principales: | Egyed, Bálint, Horváth, Anna, Semsei, Ágnes F., Szalai, Csaba, Müller, Judit, Erdélyi, Dániel J., Kovács, Gábor T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016120/ https://www.ncbi.nlm.nih.gov/pubmed/35449729 http://dx.doi.org/10.3389/pore.2022.1610096 |
Ejemplares similares
-
MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia
por: Egyed, Bálint, et al.
Publicado: (2020) -
Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
por: Rzepiel, Andrea, et al.
Publicado: (2019) -
Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia
por: Sági, Judit C., et al.
Publicado: (2021) -
Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma
por: Sági, Judit C., et al.
Publicado: (2018) -
Roles of Genetic Polymorphisms in the Folate Pathway in Childhood Acute Lymphoblastic Leukemia Evaluated by Bayesian Relevance and Effect Size Analysis
por: Lautner-Csorba, Orsolya, et al.
Publicado: (2013)